Disease: Pascual Castroviejo syndrome
- Abnormal origin of middle cerebral artery in the basilar artery
- Another case of cerebro-facio-thoracic dysplasia (Pascual-Castroviejo syndrome)
- Bilateral spinal neurofibromas in patients with neurofibromatosis 1
- Cerebro-facio-thoracic dysplasia (Pascual-Castroviejo syndrome): Identification of a novel mutation, use of facial recognition analysis, and review of the literature
- Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review
- Cutaneous and leptomeningeal hemangiomas with impressive benign evolution
- Cutaneous, mediastinal and hepatic hemangiomas in a girl followed during 12 years
- Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria
- Expanding CEP290 mutational spectrum in ciliopathies
- Hand and finger anomalous developmental coordination to write in children with attention deficit/hyperactivity syndrome
- Hemangiomas, and cutaneous and intracranial vascular deformations (Pascual-Castroviejo syndrome tipe II ). A case report
- Joint presentation of facial hemangioma, posterior fossa malformation, and carotid-vertebral hypoplasia (Pascual-Castroviejo syndrome II): report of 2 new cases
- Major and minor arterial malformations in patients with cutaneous vascular abnormalities
- Neurosurgical treatment of tuberous sclerosis complex lesions
- Novel TMEM67 mutations and genotype-phenotype correlates in meckelin-related ciliopathies
- Pascual-Castroviejo syndrome II: Association of facial hemangioma, posterior fossa malformation and congenital heart defect
- Pascual-Castroviejo type II syndrome (P-CIIS). Importance of the presence of persistent embryonic arteries
- Phenotypic spectrum and prevalence of INPP5E mutations in Joubert syndrome and related disorders
- Prevalence and Clinical Characteristics of Headaches in PHACE Syndrome
- Rhombencephalic synapsis
- Segmental neurofibromatosis type 1 (NF1) associated with Cobb syndrome: case report
- Sturge-Weber syndrome: study of 55 patients
- Two years of growth hormone treatment in the first growth hormone deficient patient with cerebrofaciothoracic dysplasia